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A B S T R A C T
Background
The World Health Organization recommends that abortion can be provided at the lowest level of the healthcare system. Training mid-
level providers, such as midwives, nurses and other non-physician providers, to conduct first trimester aspiration abortions and manage
medical abortions has been proposed as a way to increase women’s access to safe abortion procedures.
Objectives
To assess the safety and effectiveness of abortion procedures administered by mid-level providers compared to doctors.
Search methods
We searched the CENTRAL Issue 7, MEDLINE and POPLINE databases for comparative studies of doctor and mid-level providers
of abortion services. We searched for studies published in any language from January 1980 until 15 August 2014.
Selection criteria
Randomised controlled trials (RCTs) (clustered or not clustered), prospective cohort studies or observational studies that compared
the safety or effectiveness (or both) of any type of first trimester abortion procedure, administered by any type of mid-level provider or
doctors, were eligible for inclusion in the review.
Data collection and analysis
Two independent review authors screened abstracts for eligibility and double-extracted data from the included studies using a pre-tested
form. We meta-analysed primary outcome data using both fixed-effect and random-effects models to obtain pooled risk ratios (RR)
with 95% confidence intervals (CIs). We carried out separate analyses by study design (RCT or cohort) and type of abortion procedure
(medical versus surgical).
Main results
Eight studies involving 22,018 participants met our eligibility criteria. Five studies (n = 18,962) assessed the safety and effectiveness
of surgical abortion procedures administered by mid-level providers compared to doctors. Three studies (n = 3056) assessed the safety
and effectiveness of medical abortion procedures. The surgical abortion studies (one RCT and four cohort studies) were carried out in
the United States, India, South Africa and Vietnam. The medical abortion studies (two RCTs and one cohort study) were carried out
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in India, Sweden and Nepal. The studies included women with gestational ages up to 14 weeks for surgical abortion and nine weeks
for medical abortion.
Risk of selection bias was considered to be low in the three RCTs, unclear in four observational studies and high in one observational
study. Concealment bias was considered to be low in the three RCTs and high in all five observational studies. Although none of the
eight studies performed blinding of the participants to the provider type, we considered the performance bias to be low as this is part
of the intervention. Detection bias was considered to be high in all eight studies as none of the eight studies preformed blinding of
the outcome assessment. Attrition bias was low in seven studies and high in one, with over 20% attrition. We considered six studies to
have unclear risk of selective reporting bias as their protocols had not been published. The remaining two studies had published their
protocols. Few other sources of bias were found.
Based on an analysis of three cohort studies, the risk of surgical abortion failure was significantly higher when provided by mid-level
providers than when procedures were administered by doctors (RR 2.25, 95% CI 1.38 to 3.68), however the quality of evidence for this
outcome was deemed to be very low. For surgical abortion procedures, we found no significant differences in the risk of complications
betweenmid-level providers and doctors (RR 0.99, 95%CI 0.17 to 5.70 fromRCTs; RR 1.38, 95%CI 0.70 to 2.72 from observational
studies). When we combined the data for failure and complications for surgical abortion we found no significant differences between
mid-level providers and doctors in both the observational study analysis (RR 1.36, 95% CI 0.86 to 2.14) and the RCT analysis (RR
3.07, 95% CI 0.16 to 59.08). The quality of evidence of the outcome for RCT studies was considered to be low and for observational
studies very low. For medical abortion procedures the risk of failure was not different for mid-level providers or doctors (RR 0.81, 95%
CI 0.48 to 1.36 from RCTs; RR 1.09, 95% CI 0.63 to 1.88 from observational studies). The quality of evidence of this outcome for
the RCT analysis was considered to be high, although the quality of evidence of the observational studies was considered to be very
low. There were no complications reported in the three medical abortion studies.
Authors’ conclusions
There was no statistically significant difference in the risk of failure for medical abortions performed by mid-level providers compared
with doctors.Observational data indicate that theremay be a higher risk of abortion failure for surgical abortion procedures administered
by mid-level providers, but the number of studies is small and more robust data from controlled trials are needed. There were no
statistically significant differences in the risk of complications for first trimester surgical abortions performed by mid-level providers
compared with doctors.
P L A I N L A N G U A G E S U M M A R Y
Can health care providers who are not doctors perform abortions as well as doctors?
Unsafe abortion causes death and disability and remains a major public health concern in developing countries. Most of these deaths
and disabilities could be prevented if safe and legal abortion were provided by trained people. This review looked at whether using
mid-level providers (health care providers who are not doctors) to perform abortions is safe. It also looked at whether the abortions
provided by mid-level providers worked as well as those provided by doctors.
We carried out searches for studies that compared medical abortion (using pills) or surgical abortion provided by either mid-level
providers or doctors. We also wrote to researchers to find more studies. The studies could compare how safe the abortions were or how
effective they were (whether they actually worked). The evidence we found is up to date as of the 15th of August 2014.
We found eight studies with a total of 22,018 participants. Five studies compared surgical abortion provided by doctors or mid-level
providers and three studies compared medical abortion provided by doctors or mid-level providers. Of the five surgical abortion studies
only one had a high-quality study design. Of the three medical abortion studies, two had a high-quality study design. Three of these
studies were carried out in America, two in India, one in was carried out in both South Africa and Vietnam the remaining two were
from Sweden and Nepal.
The results from the analyses of the medical abortion studies showed that there does not seem to be an advantage when these are
provided by doctors. The results from most of the analyses of the surgical abortion studies showed that we cannot be sure that there
is a difference in how safe and how effective mid-level providers are compared to doctors. One analysis of three low-quality studies of
surgical abortion showed that there was more chance of the abortion being ineffective if it was provided by mid-level providers.
Most of the studies did not show a difference between mid-level providers and doctors in how safe the abortions were and how well they
worked. Training mid-level providers to give medical or surgical abortions could reduce the number of deaths and the disability caused
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by unsafe abortion. Studies in the future should focus on what types of mid-level providers can provide safe and effective abortions.
They should also look at whether mid-level providers are as safe and effective as doctors for providing abortions in rural developing
country settings.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Surgical abortion procedures: mid-level providers compared to doctors
Patient or population: Patients requesting abortion procedures
Settings: Hospital or clinic
Intervention: Surgical abortion administered by mid-level providers
Comparison: Surgical abortion administered by doctors
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Control Mid-level providers
Failure/incomplete
abortion (RCTs)
Provider assessment
Follow-up: 10 to 14 days
6 per 1000 17 per 1000
(1 to 241)
RR 2.97
(0.21 to 41.82)
2789
(2 studies)
⊕⊕©©
low3
-
Fail-
ure/incomplete abortion
(observational studies)
Provider or supervisor as-
sessment
Follow-up: 7 to 28 days
3 per 1000 7 per 1000
(4 to 12)
RR 2.2
(1.34 to 3.6)
13,715
(3 studies)
⊕©©©
very low1
-
Complications (RCTs)
Provider assessment
Follow-up: 10 to 14 days
1 per 1000 1 per 1000
(0 to 8)
RR 0.99
(0.17 to 5.7)
2789
(2 studies)
⊕⊕©©
low3
-
Complications (observa-
tional studies)
Provider or supervisor as-
sessment
Follow-up: 7 to 28 days
7 per 1000 10 per 1000
(5 to 19)
RR 1.38
(0.7 to 2.72)
13,715
(3 studies)
⊕©©©
very low1,2
-
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Total complications
(RCTs)
Provider assessment
Follow-up: 10 to 14 days
7 per 1000 22 per 1000
(1 to 425)
RR 3.07
(0.16 to 59.08)
2789
(2 studies)
⊕⊕©©
low3
-
Total complications (ob-
servational studies)
Provider or supervisor as-
sessment
Follow-up: 7 to 28 days
13 per 1000 18 per 1000
(11 to 28)
RR 1.36
(0.86 to 2.14)
16,173
(4 studies)
⊕©©©
very low1,2
-
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval;RCT: randomised controlled trial; RR: risk ratio
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 Quality of evidence was downgraded from Low to Very Low due to Risk of bias. The proportion of information from studies at high
risk of bias is sufficient to affect the interpretation of results. All studies are observational studies. Blinding in abortion studies is not
feasible (ethical) .
2 Quality of evidence was downgraded from Low to Very Low due to Study Limitations and Imprecision (Wide confidence intervals for
Jejeebhoy 2011).
3No events in the doctors group in South Africa.
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B A C K G R O U N D
Description of the condition
Unsafe abortion remains a major public health concern in devel-
oping countries. Despite the existence of safe and effective surgical
methods (Kulier 2009), and medical methods to induce abortion
(Kulier 2011), an estimated 22 million unsafe abortions are per-
formed each year, resulting in the deaths of 47,000women and dis-
abilities for an additional five million women (Sedgh 2012). Most
of these deaths and disabilities could be prevented through the
provision of safe and legal induced abortion by qualified providers.
To ensure that women living in developing countries can readily
access safe termination procedures, the World Health Organiza-
tion (WHO) recommends that abortion can be provided at the
lowest level of the healthcare system (WHO 2008). However, in
many developing countries, even in settings where abortion is le-
gal, access to abortion remains limited due to a shortage of trained
physicians.
Irrespective of legal conditions, in settings where access to safe
abortion care is lacking, women often obtain termination services
from unqualified or unskilled providers (WHO 2012). Therefore,
training mid-level providers (midwives, nurses and other non-
physicianproviders) to conduct first-trimester aspiration abortions
and manage medical abortions has been proposed as a way to in-
crease women’s access to safe abortion procedures (Berer 2009).
Description of the intervention
In order to address the shortage of human resources for abortion
services, mid-level providers have been used in a number of set-
tings. Mid-level providers are midwives or any other healthcare
worker who has less training than doctors and provides clinical
care. There are two methods of abortion: medical and surgical.
Medical abortion is the use of drugs to induce abortion. The
gold standard for this therapy is a combination of mifepristone
and misoprostol. Surgical abortion uses transcervical procedures
to terminate the pregnancy, including manual vacuum aspiration
(MVA) and dilation and evacuation. Both are safe and effective
methods for abortion that are recommended by theWorld Health
Organization (WHO 2012).
How the intervention might work
Authorising and training mid-level providers to provide abortion
could reduce the number of unsafe procedures and alleviate the
burden on healthcare systems. A review of medical abortion ser-
vice delivery has suggested that the provision and management
of medical abortion by mid-level providers is cost-effective in re-
source-limited settings due to salary costs and the scarcity of physi-
cians (Berer 2009). However, not all countries across the world
adopt this practice. Inmany developed country settings, including
France and theUK (Jones 2000), nurses andmidwives are not per-
mitted to manage and administer abortion procedures indepen-
dently. Only a handful of countries in the developing world per-
mit midwives to perform aspiration abortion (Cambodia (Long
2001) and South Africa) or paramedics to carry out ’menstrual
regulation’ procedures (Bangladesh). In many countries, national
policies limit access to medical abortion by restricting its prescrip-
tion and provision to certified physicians (Yarnall 2009).
Why it is important to do this review
Training mid-level providers to conduct aspiration abortions and
manage medical abortions has been proposed as a way to increase
women’s access to safe abortion. However, only a few countries
across the world have adopted this practice. Restrictions on mid-
level provision are mainly due to concerns about the standard of
care and safety of the abortions provided. In order to inform clin-
ical practice and policy regarding abortion provision, a review of
the evidence on the effectiveness and safety of abortion proce-
dures performed by mid-level providers compared with doctors is
therefore needed. This review aims to update a previous system-
atic review published in 2012 (Ngo 2013). This review included
published studies assessing the effectiveness or safety (or both) of
abortion provided by mid-level providers compared with proce-
dures provided by doctors. For the purposes of this review, we will
define mid-level providers as any trained health professionals who
are not physicians (WHO 2010).
O B J E C T I V E S
To assess the safety and effectiveness of abortion procedures ad-
ministered by mid-level providers compared to doctors.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included RCTs and cohort studies that assessed the safety and
effectiveness of surgical or medical abortion procedures adminis-
tered by mid-level providers compared to doctors.
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Types of participants
We included women of any age, in any setting who were seeking
abortion procedures (gestational age less than 14weeks for surgical
abortion and less than nine weeks for medical abortion).
Types of interventions
We included any type of abortion procedure provided by ei-
ther doctors or mid-level providers in any setting. Mid-level
providers included nurses, nurse practitioners, ayurvedic practi-
tioners, physician assistants, midwives, auxiliary nurse midwives
and certified nurse midwives. Mid-level providers worked inde-
pendently when carrying out the abortion procedure.
Types of outcome measures
Primary outcomes
• Failure/incomplete abortion, including continuing
pregnancy at follow-up and incomplete abortion.
• Complications of abortion, including haematometra,
haemorrhage, endocervical injury, anaesthesia-related reactions,
uterine perforation, infection, injury to bowel, any complication
requiring blood transfusion and any complication requiring
hospitalisation.
Secondary outcomes
• Total complications (incomplete or failed abortion and
complications).
Search methods for identification of studies
Electronic searches
We carried out a search on the 15th of August 2014. We searched
the Cochrane Central Register of Controlled Trials Issue 7, Ovid
MEDLINE and POPLINE for studies assessing the effectiveness
and safety of mid-level provision of abortion, using the following
terms:
(((“Nurses”[Mesh] OR “Physician Assistants”[Mesh] OR “mid-
level provider”[text word] OR “mid-level providers”[text word]
ORnurse*[text word]ORmidwife*[text word]ORmidwives[text
word] OR “nurse practitioner”[text word] OR “nurse practition-
ers”[text word]OR “physician assistant”[text word]OR “physician
assistants”[text word] OR “non-physician”[text word] OR “non-
physicians”[text word] OR “substitute health worker”[text word]
OR “substitute health workers”[text word] OR auxiliar*[text
word]) AND (“Abortion, Incomplete”[Mesh] OR “Abortion, In-
duced”[Mesh:noexp] OR “Abortion, Legal”[Mesh] OR “Abor-
tion, Therapeutic”[Mesh:noexp] OR abortion*[text word])))
AND (“1980”[Date - Publication] : “3000”[Date - Publication])
We restricted the search results to studies published after 1980
through to 15th August 2014 for all databases.We placed no limits
on language.
Searching other resources
We handsearched the reference lists of key articles and also con-
tacted investigators in the field to find studies that were not iden-
tified in the electronic search, including unpublished reports. We
also searched the EU clinical trials register, ICTRP and ISRCTN
registers for publications of protocols.
Data collection and analysis
Selection of studies
Two review authors (SB, CK) independently screened the titles
and abstracts of studies for eligibility. We retrieved the full text of
potentially eligible studies and applied the inclusion criteria to the
retrieved publications. We sought further information from the
authors where papers contained insufficient information to make
a decision about eligibility. There was good inter-rater agreement
(kappa coefficient = 0.619). We resolved disagreements about the
inclusion of studies by consensus.
Data extraction and management
Two independent authors (SB, CK) double-extracted data using a
pre-designed standard form. We checked the extracted data from
each review author against each other and, if necessary, made ref-
erence to the original paper.We resolved any outstanding discrep-
ancies by consensus. Where necessary, we also contacted study
authors twice over a period of two months in an attempt to ob-
tain any missing information. One author (SB) entered the data
into Review Manager (RevMan 2014), and another author (CK)
checked the entries for accuracy.
Assessment of risk of bias in included studies
Two authors assessed the risk of bias for the included studies in
the following domains: selection bias, performance bias, detection
bias, attrition bias, reporting bias and other biases and recorded
this in the ’Risk of bias’ tables. We ranked the studies as ’low
risk’, ’high risk’ or ’unclear risk’ using the criteria recommended
by theCochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011).
We used the GRADE approach to assess the quality of the body of
evidence used inmeta-analysis (Higgins 2011). Using theGRADE
methods we assessed within-study risk of bias (methodological
quality), directness of evidence, heterogeneity, precision of effect
estimates and risk of publication bias. We rated the quality of the
body of evidence as high, moderate, low or very low.
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Measures of treatment effect
The main measures of effect were pooled risk ratios (RRs) of the
primary outcomes (failure, complications, failure + complications)
for mid-level providers compared to doctors. Data on the number
of events and number of participants assigned to each treatment
group were meta-analysed using Mantel-Haenszel fixed-effect and
random-effectsmodels (Higgins 2011;RevMan 2014). For studies
that included rates rather than number of events, we contacted
study authors for data relating to the number of events. If the study
authors did not respond, we calculated the number of events using
the rates reported in the study.
Unit of analysis issues
For all included studies, we assessed whether an appropriate anal-
ysis had been done that adjusted for clustering by provider in cal-
culating measures of precision. Two studies adjusted for clustering
at the design stage (by increasing the sample size) and in analy-
sis (Kopp Kallner 2015; Warriner 2011). Four studies increased
the sample size by 10% to 15% in order to adjust for clustering
(Jejeebhoy 2011; Jejeebhoy 2012; Warriner 2006; Weitz 2013).
Two studies did not mention adjustment for clustering in their
methods (Freedman 1986; Goldman 2004). We were unable to
adjust for clustering in the meta-analysis as we were unable to ob-
tain the raw data.
When analysing the data for failure and incomplete abortion for
medical abortion RCTs (Kopp Kallner 2015; Warriner 2011), we
used the per protocol analysis data from each study.
Dealing with missing data
We attempted to obtain missing data from the authors. If we did
not receive a response we did not attempt to impute missing data.
Assessment of heterogeneity
We determined clinical heterogeneity using the I2 statistic and
qualitative assessment of forest plots. We used a random-effects
model for meta-analysis if the I2 statistic was ≥ 50% and we
identified heterogeneity qualitatively.We used a fixed-effectmodel
if the I2 statistic was≤ 50% and we did not identify heterogeneity
qualitatively.
Assessment of reporting biases
We assessed selective outcome reporting as a risk of bias criterion,
as described in the Cochrane Handbook for Systematic Reviews of
Interventions (Higgins 2011). In order to identify differences be-
tween outcomes in the study protocol and in the published study
we searched databases for publication of protocols and contacted
study authors if the protocol was not available. Finally, we com-
pared the outcomes reported between the studies included in the
review.
Data synthesis
Over a period of a month we attempted to contact several re-
searchers by email for supplemental data. If we did not receive a
response, we did not attempt to impute the data. One author en-
tered the data into Review Manager (RevMan 2014), and another
author checked the entries for accuracy.
For the surgical abortion studies, we carried out meta-analyses
for failure (including incomplete abortion), complications and for
complications including failure and incomplete abortion. For the
medical abortion studies we carried out meta-analysis for failure,
including incomplete abortions. All meta-analyses used Mantel-
Haenszel models and we used the Review Manager software (
RevMan 2014). We analysed and presented RCTs independently
of cohort studies. As there was only one cohort study for medical
abortion, we carried out no meta-analysis.
Subgroup analysis and investigation of heterogeneity
No subgroup analyses were conducted. We investigated hetero-
geneity using both the I2 statistic and visual inspection.
Sensitivity analysis
We separately analysed RCTs and non-RCTs to assess the effect
of study quality on the main outcomes. We performed sensitivity
analysis for immediate and delayed complications and developing
and developed settings.
R E S U L T S
Description of studies
Results of the search
There were 1525 citations identified in the search, of which 253
were duplicates. Of the 1273 unique citations, we excluded 1185
citations based on title screening. We identified 87 titles as po-
tentially relevant and screened the abstracts for retrieval. Based on
abstract screening, we excluded 73 citations and retrieved full texts
for 15 citations. Eight studies met the inclusion criteria; of these,
five had been included in the Ngo 2013 review and we identified
two more recent studies. We identified an additional study in July
2014. All studies were published in English (Figure 1).
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Figure 1. Study flow diagram.
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Included studies
We included eight studies in this review (Characteristics of
included studies), comprising five prospective cohort studies and
three randomised controlled trials (RCTs). A total of 22,018
women were included across the eight studies; of these, 11,091
women underwent a procedure administered by a mid-level
provider (9339 had surgical abortion; 1752 hadmedical abortion)
and 10,927 women underwent a physician-administered proce-
dure (9623 had surgical abortion; 1304 had medical abortion).
All studies took place in either a hospital or a specialist health
clinic, such as a women’s health centre or sexual and reproductive
health clinic. Studies are described in detail in the Characteristics
of included studies table. One RCT of manual vacuum aspira-
tion (MVA) procedures administered by mid-level providers and
physicians took place in South Africa (n = 1153) and Vietnam (n =
1636) in 2003 (Warriner 2006). The other RCTs were carried out
in Nepal in 2009 (n = 976) (Warriner 2011) and Sweden in 2011
(n = 916) (Kopp Kallner 2015), and compared the outcomes of
medical abortion procedures administered by mid-level providers
and physicians. The five prospective cohort studies (n = 7939) as-
sessed surgical abortion procedures conducted in the US in 1981
(Freedman 1986), 1997 (Goldman 2004) and 2012 (Weitz 2013),
in India in 2009 (Jejeebhoy 2011), and medical abortion in India
in 2010 (Jejeebhoy 2012).
The included studies are described below, by type of abortion
(surgical or medical).
Surgical abortion studies
A RCT conducted in South Africa and Vietnam compared the
outcomes of MVA procedures for pregnancies up to 12 weeks ges-
tation delivered by mid-level providers, with government-accred-
ited training in abortion, and those administered by physicians
(Warriner 2006). The number of years of provider experience dif-
fered between mid-level providers and doctors in both countries.
In the South African study the median experience for doctors
was seven years while for mid-level providers the median num-
ber of years experience was four years. In Vietnam, the mid-level
providers had a median of seven years of experience, while doctors
had a median of 10 years of experience. All participants were of-
fered lidocaine and additional oral analgesia; in one of the study
locations (South Africa), misoprostol 400 mg was administered
two to three hours before the procedure. Women were followed
up 10 to 14 days after the procedure. The outcomes of interest
were: total complication rates for mid-level providers and doctors
by time of complication; total number of women reporting ad-
verse symptoms at follow-up interviews for mid-level providers
and doctors.
Four prospective cohort studies used surgical abortion methods
(Freedman 1986; Goldman 2004; Jejeebhoy 2011; Weitz 2013).
One study, conducted in the US, used early uterine evacuation or
suction curettage (Freedman 1986), delivered by either a physician
assistant or a physician; women arriving at the clinic were seen by
the next available provider and were followed upwithin four weeks
of the procedure. The outcomes of interest were: total complica-
tion rates for physician assistants and physicians by procedure and
weeks gestation; total complication rates by procedure and time
of complication; distribution of complications by procedure and
time of complication.
In another US study (Goldman 2004), physicians with at least
five years experience in abortion procedures performed standard
vacuum curettage procedures for pregnancies up to 12 weeks ges-
tation, while physician assistants with the same level of experience
providedMVA or standard vacuum curettage procedures for preg-
nancies up to 14 weeks gestation. Follow-up was within 14 days of
the procedure. The outcomes of interest were: total complication
rates by site and time of occurrence; procedures with complication
by gestational age and abortionmethod; complication type by site.
A study conducted in India used MVA delivered by nurses or
physicians with no previous experience of providing any type of
abortion, who underwent 10 days of MVA training as part of the
study (Jejeebhoy 2011). All abortion procedures were conducted
in the presence of a qualified supervisor. Women were followed
up after seven days. The outcomes of interest were: accuracy of
assessment of gestational age for nurses and physicians; accuracy
of assessment of other criteria relating to eligibility for nurses and
physicians; assessment of complete abortion for nurses and physi-
cians; rate of complete abortion by day seven by nurses and physi-
cians; overall complication rate for nurses and physicians; compli-
cation rates (not including failure) for nurses and physicians.
The most recent study was conducted in the USA (Weitz 2013),
and compared complication rates within four weeks of aspira-
tion abortion for nurse practitioners, certified nurse midwives and
physician assistants to those of physicians. Providers were trained
to competency in the provision of aspiration abortion and had a
California professional license and basic life support. The mean
number of years of experience differed betweenmid-level providers
and physicians. The mean number of years experience of mid-
level providers’ was 1.5 years while for physicians it was 14 years.
Providers performed aspiration abortion on participants with less
than 14 weeks gestation. Follow-up was within four weeks of the
procedure. The outcomes of interest were: incidence of major and
minor complications within four weeks of aspiration abortion for
nurse practitioners, certified nurse midwives, physician assistants
and physicians.
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Medical abortion studies
Three studies (two RCTs and one cohort study) assessed the safety
and effectiveness of mid-level providers for medical abortion pro-
cedures (Jejeebhoy 2012; Kopp Kallner 2015; Warriner 2011).
The cohort study used a medical abortion regimen of 200 mg of
mifepristone orally followed by 400 µg of misoprostol orally two
days later for women of up to eight weeks gestation (Jejeebhoy
2012). The regimen was delivered by ayurvedic physicians, nurses
and allopathic physicians in abortion clinics in India. Only
providers who had never performed surgical or medical abor-
tion, never conducted pelvic examinations or never assessed gesta-
tional age were recruited. All underwent identical medical train-
ing, which lasted 10 days. Women were followed up after 15 and
21 days (if extended follow-up was advised). The outcomes of in-
terest were: observed failure rates for ayurvedic physicians, nurses
and allopathic physicians; complication rates for ayurvedic physi-
cians, nurses and allopathic physicians; accuracy of eligibility as-
sessment for nurses and allopathic physicians; accuracy of assess-
ment of abortion completeness for nurses and allopathic physi-
cians; acceptability for nurses and allopathic physicians (client sat-
isfaction).
Both RCTs used a medical abortion regimen of 200 mg mifepri-
stone orally followed by 800 mg of misoprostol vaginally one to
two days later for pregnancies up to nine weeks of gestational age.
The Nepali study compared the safety and efficacy of staff nurses
and auxiliary midwives trained in MVA to doctors (obstetricians,
gynaecologists, general practitioners and other doctors) for medi-
cal abortion across five district hospitals in Nepal (Warriner 2011).
The demographic data for the participants were similar to the so-
cio-demographic characteristics of women typically seeking abor-
tions in Nepal. Mid-level providers had a median of 25 years of
professional medical practice experience compared to a median of
15 years for doctors. All providers underwent a three-day training
course inmedical abortion.Womenwere followedup10 to14days
after the procedure. The outcomes of interest were: failed abor-
tion and continuing pregnancy at 30 days for mid-level healthcare
providers and doctors; the extent to which each group provided
medical abortion procedures independently; serious adverse events
by provider type.
The Swedish RCT compared the efficacy, safety and acceptabil-
ity of nurse midwives or doctors providing medical abortion at
the outpatient family planning clinic of a university hospital in
Stockholm (Kopp Kallner 2015). Two nurse-midwives who were
experienced in medical abortion and contraceptive counselling re-
ceived theoretical and practical training in vaginal ultrasound ex-
amination of early pregnancy. A total of 34 doctors with vary-
ing levels of experience and training were involved in the study.
Women randomised to the nurse midwife group were examined,
counselled, informed and treated by a single nurse-midwife. Par-
ticipating nurse midwives did not perform any regular nurse mid-
wife duties during the study period. Women randomised to the
doctors group were examined and counselled by a doctor, and then
received additional information from a nurse midwife. Follow-up
was at three weeks for failure and six weeks for complications, in-
cluding incomplete abortion. The outcomes of interest were: effi-
cacy, defined as the need for surgical intervention; safety, defined
as no unscheduled visit within six weeks of medical abortion; and
acceptability, defined as women preferring their allocated provider.
Excluded studies
We excluded six reports, which we had examined in full text. Two
studies did not provide a comparison group and one did not fit the
inclusion criteria for this review. Three reports that we retrieved
were commentaries or narrative pieces. The remaining title listed
no authors and could not be retrieved. This has been classified as
’awaiting classification’. (See table of Characteristics of excluded
studies for more details).
Risk of bias in included studies
Allocation
Themethod of sequence generationwas described in all eight stud-
ies. We considered selection bias associated with sequence gener-
ation to be low in three studies, unclear in four studies and high
in one study (Figure 2; Figure 3).
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Figure 2.
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Figure 3.
The three randomised trials used a computer-generated randomi-
sation scheme, giving each study a low risk of bias (Kopp Kallner
2015; Warriner 2006; Warriner 2011).
Although the remaining studies were observational studies,
each described their method of allocation sequence generation.
Freedman 1986 had the participants seen by the next available
provider. Jejeebhoy 2011 described the sequence generation as
“naturally random” by having one type of provider at each facility
until they had completed the required number of vacuum aspira-
tions. Jejeebhoy 2012 used the same methods, assigning providers
to clinics until they had completed a required number of medical
abortions. The most recent study, Weitz 2013, observed the out-
comes of various providers at several health centres. While these
four studies did not carry out random sequence generation, treat-
ment allocation was not dependent on risk of failure or complica-
tions, therefore we considered the risk of selection bias to be un-
clear. Goldman 2004 compared two clinics in different US states,
one clinic where the providers were physicians and the other where
the providers were physician assistants. We assessed the risk of se-
lection bias in this observational study to be high as the settings
differed between states.
We considered allocation concealment bias to be low in three
studies and high in five studies. For the three randomised studies,
there was adequate allocation concealment. All three studies used
sealed, opaque envelopes that contained the random allocation of
the provider type. These envelopes were sequentially numbered
and opened once written consent was obtained (Kopp Kallner
2015; Warriner 2006; Warriner 2011). There was no allocation
concealment in the five observational studies (Freedman 1986;
Goldman 2004; Jejeebhoy 2011; Jejeebhoy 2012; Weitz 2013).
Blinding
None of the eight studies performed blinding of participants. The
participants’ knowledge of the provider type is part of the inter-
vention, therefore it is a better reflection of the real world effec-
tiveness of the intervention. We considered this a low risk of bias
as it is part of the intervention.
None of the eight studies performed blinding of outcome assess-
ment. We considered this a high risk of bias.
Incomplete outcome data
We considered attrition bias to be low in seven studies and high
in one study. We considered loss to follow-up of greater than 20%
to threaten study validity (Strauss 2005). We noted the Goldman
2004 study to have a loss to follow-up of 28.5% (Goldman 2004).
Another study reported a loss to follow-up of 30%, however this
loss was similar in both provider groups (Weitz 2013). The rest
of the studies achieved a low rating for attrition bias due to their
minimal loss to follow-up rate. These six studies had a low loss to
follow-up rate (3% for Freedman 1986, 3.6% for Jejeebhoy 2011,
5% for Jejeebhoy 2012, 3.6% forWarriner 2006, 4% forWarriner
2011 and 12% for Kopp Kallner 2015).
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Selective reporting
Weconsidered six studies to have anunclear risk of bias for selective
reporting. One study had published their protocol (Weitz 2013).
Three studies did not publish their protocol prior to data collection
but did make it available (Jejeebhoy 2011; Jejeebhoy 2012; Kopp
Kallner 2015). It is unknown whether the protocols are available
for the remaining four studies.
Other potential sources of bias
Only one of the eight studies had other sources of bias. Goldman
2004 had varied levels of clinician training between provider type,
which introduced a type of performance bias.
In two studies, mid-level providers and doctors worked from dif-
ferent clinics, therefore reducing the opportunity for mid-level
providers to discuss clinical concerns (Goldman 2004; Jejeebhoy
2011). In one study, although mid-level providers and doctors
were operating from the same site, a separate waiting area and
examination rooms were provided to reduce interactions between
providers and to act as a surrogate for how providers would man-
age in an independent setting (Warriner 2011). Four studies had
mid-level providers and doctors operating from the same site with
no restrictions on interaction between providers (Freedman 1986;
Kopp Kallner 2015; Warriner 2006; Weitz 2013). In two studies,
although mid-level providers worked independently, their assess-
ments of failure were verified by a higher-level clinician (Jejeebhoy
2011; Jejeebhoy 2012). Heterogeneity between studies makes it
difficult to discuss the safety and efficacy of mid-level providers
carrying out abortion procedures independently from doctors.
This review analysed raw unadjusted data in order to make com-
parisons between studies. As a result we have not been able to
control for confounding in non-randomised studies. The quality
of the analyses of non-randomised studies has been downgraded
as a result. Future versions of the review should attempt to analyse
adjusted effect estimates when analysing non-randomised studies.
Effects of interventions
See: Summary of findings for the main comparison Surgical
abortion procedures: mid-level providers compared to doctors;
Summary of findings 2 Medical abortion procedures: mid-level
providers compared to doctors
Surgical abortion
Failure/incomplete abortion
Failure/incomplete abortion included continuing pregnancy at
follow-up and incomplete abortion. Incomplete abortion was de-
fined in four out of five of the surgical abortion studies as retained
products of conception necessitating re-evacuation. One study did
not specify the definition of incomplete abortion (Weitz 2013).
In the randomised controlled trial (RCT) of surgical abortion, of
the 1400 women who had a procedure provided by a mid-level
provider, 1.1% (n = 16) experienced a failed or incomplete abor-
tion. Among the 1389 women who had an abortion provided by a
doctor, 0.6% (n = 8) experienced a failed or incomplete abortion.
There was no significant difference in the risk of failure among
women who had a procedure provided by a mid-level provider
and those who had a procedure provided by a physician (risk ratio
(RR) 2.97, 95% confidence interval (CI) 0.21 to 41.82) (Analysis
1.1).
In the three cohort studies that reported failure/incomplete abor-
tion independently of total complication rates, 6654 women had
an abortion procedure provided by a mid-level provider. Of these
women, 0.7% (n = 47) experienced a failed or incomplete abor-
tion. Of the 7061 women who had an abortion provided by a
physician, 0.3% (n = 23) experienced a failed or incomplete abor-
tion. The risk of failure or incomplete abortion was higher among
women who had a procedure provided by a mid-level provider
(pooled RR 2.25, 95% CI 1.38 to 3.68) (Analysis 1.2; Figure 4 ).
Figure 4. Forest plot of comparison: 1 Mid-level providers versus doctors, outcome: 1.2 Failure/incomplete
surgical abortion (observational studies).
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Complications
Complications of abortion included haematometra, haemorrhage,
endocervical injury, anaesthesia-related reactions, uterine perfora-
tion, infection, injury to the bowel, any complication requiring
blood transfusion and any complication requiring hospitalisation.
The RCT of surgical abortion showed that of the 1400 women
who had a procedure delivered by a mid-level provider, 0.1% (n
= 2) experienced a complication. The same proportion of women
experienced a complication among the 1389 women who had a
procedure provided by a physician (n = 2). There was no difference
between provider types in the risk of complications (RR0.99, 95%
CI 0.17 to 5.70) (Analysis 1.3).
In the three cohort studies that reported complications indepen-
dently from failure, 6654 women had an abortion procedure pro-
vided by amid-level provider. The proportion of those who experi-
enced a complication in this group was 1.0% (n = 68). Among the
7061 women who had a procedure provided by a physician, 0.7%
(n = 49) experienced a complication. There was no significant dif-
ference between procedures provided by mid-level providers and
those provided by doctors in the risk of complications (pooled RR
1.38, 95% CI 0.70 to 2.72) (Analysis 1.4).
Total complications (incomplete or failed abortion and
complications)
Total complications included failure and incomplete abortion, re-
tention of products of pregnancy, haematometra, haemorrhage,
endocervical injury, anaesthesia-related reactions, uterine perfora-
tion, infection, injury to the bowel, any complication requiring
blood transfusion and any complication requiring hospitalisation.
In the RCT, data for total complications were available for 1400
women who had procedures administered by mid-level providers.
The proportion of total complications among this group was 1.3
% (n = 18) for surgical abortion (Warriner 2006). Among the 1389
women who had abortion procedures provided by physicians in
these trials, the proportion of total complications was 0.7% (n
= 10) for surgical procedures (RR 3.07, 95% CI 0.16 to 59.08)
(Analysis 1.5).
In the four cohort studies of surgical abortion, the proportion of
total complications among women who had a procedure admin-
istered by a mid-level provider (n = 7939) was 1.9%. Among the
8234 women who had a procedure provided by a physician, the
proportion of women who experienced failure or complication
was 1.3%. There was no significant difference in the risk of failure
or complication among women who had a procedure provided by
a mid-level provider compared with those who had a procedure
administered by a physician (pooled RR 1.36, 95% CI 0.86 to
2.14) (Analysis 1.6).
Medical abortion
Failure/incomplete abortion
Failure or incomplete abortion was defined by two studies as the
need for surgical evacuation. One study defined failure as urinary
human chorionic gonadotropin (hCG) greater than 500 IU/ml
three weeks following medical abortion (Kopp Kallner 2015).
RCT data for failure of medical abortion or incomplete abor-
tion were derived from two studies (Kopp Kallner 2015; Warriner
2011). Among the 977 women who had a medical abortion ad-
ministered by a mid-level provider, 2.7% (n = 26) experienced
failed/incomlpete abortion. Among the 915 women who had a
medical abortion administered by a physician, 3.3% (n = 30) ex-
perienced failure or incomplete abortion. There was no signifi-
cant difference in the risk of failure or incomplete abortion be-
tween mid-level provider and physician-administered procedures
(pooled RR 0.81, 95% CI 0.48 to 1.36) (Analysis 1.7).
One cohort study reported data for failure of medical abortion
(Jejeebhoy 2012). Among the 775 women who had a mid-level
provider-administered medical abortion, 5.0% (n = 39) experi-
enced failure. Among the 389 women who had a physician-ad-
ministered procedure, 4.6% (n = 18) experienced failureor incom-
plete abotion. There was no significant difference between mid-
level provider and physician-administered procedures in the risk
of failure or incomplete abortion (RR 1.09, 95% CI 0.63 to 1.88)
(Analysis 1.8).
Complications
Complications of abortion included haematometra, haemorrhage,
endocervical injury, anaesthesia-related reactions, uterine perfora-
tion, infection, injury to the bowel, any complication requiring
blood transfusion and any complication requiring hospitalisation.
For all threemedical abortion studies, there were no reported com-
plications for either mid-level provider administered or physician
administered medical abortions.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Medical abortion procedures: mid-level providers compared to doctors
Patient or population: Patients requesting abortion procedures
Settings: Hospital or clinic
Intervention: Medical abortion administered by mid-level providers
Comparison: Medical abortion administered by doctors
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Control Mid-level providers
Failure/incomplete
abortion (RCTs)
Provider assessment
Follow-up: 30 to 42 days
33 per 1000 27 per 1000
(16 to 45)
RR 0.81
(0.48 to 1.36)
1892
(2 studies)
⊕⊕⊕⊕
high
-
Fail-
ure/incomplete abortion
(observational studies)
Verifier assessment
Follow-up: 15 to 21 days
46 per 1000 50 per 1000
(29 to 87)
RR 1.09
(0.63 to 1.88)
1164
(1 study)
⊕©©©
very low1
-
Complications (RCTs)
Provider assessment
Follow-up: 30 to 42 days
0 per 1000 0 per 1000 - 1892
(2 studies)
⊕⊕⊕⊕
high
-
Complications (observa-
tional studies)
Verifier assessment
Follow-up: 15 to 21 days
0 per 1000 0 per 1000 - 1164
(1 study)
⊕©©©
very low1
-
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*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; RCT: randomised controlled trial; RR: risk ratio
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 Quality of evidencewas downgraded from Low to Very Low due to Risk of bias. The proportion of information from studies at high
risk of bias is sufficient to affect the interpretation of results. All studies are observational studies. Blinding in abortion studies is not
feasible (ethical).
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D I S C U S S I O N
Summary of main results
There is some evidence of an increase in the risk of failure or
incomplete abortion for surgical abortion procedures provided by
mid-level providers (pooled risk ratio (RR) 2.25, 95% confidence
interval CI 1.38 to 3.68), however the absolute risk is small and
the data come from only three cohort studies. We rated the quality
of the body of evidence as very low. There is no evidence of a
statistically significant difference in the risk of total complications
(which includes abortion failure, complications alone, immediate
complications or delayed complications) when surgical abortion is
provided bymid-level providers. There is no statistically significant
evidence of a difference in the risk of failure of medical abortion
between mid-level providers and physicians. Our results suggest
that medical abortion can be carried out safely and effectively by
mid-level providers.
Overall completeness and applicability of
evidence
The findings from this review are only applicable to pregnancies
up to nine weeks for medical abortion and up to 14 weeks for sur-
gical procedures. The findings from the medical abortion studies
cannot be generalised to settings where a misoprostol-only regi-
men is used to induce abortion and is limited to settings involv-
ing the specific regimens used in these studies. This review fo-
cuses on clinical measures of effectiveness and safety as the out-
comes. Assessment of feasibility and acceptability, and barriers to
the use of mid-level provision, were beyond the scope of this re-
view, however recent findings from India and Nepal suggest that
mid-level providers found task-shifting of medical abortion provi-
sion to mid-level providers to be acceptable (Acharya 2014), and
women are happy with the service provided (Puri 2014).
’Mid-level provider’ is a broad term that is currently used by the
World Health Organization (WHO) to describe any trained prac-
titioner who is not a physician (Brown 2011). We recognise that
concerns have been raised that the term ’mid-level’ implies that
these clinicians provide a lower level of service to physicians; how-
ever, to be consistent with the WHO terminology, we have used
the term when referring to these providers collectively.
We were unable to perform an analysis of subtypes of mid-level
providers due to the heterogeneity of the training for provider types
in different settings (Mullan 2007). In addition, the role that mid-
level providers played in the intervention varied between studies.
By including a broad range of mid-level providers in our review,
we may be masking important differences between provider types
by lumping them together. We recommend that future studies are
carried out to establish the safety and effectiveness of subtypes of
mid-level providers performing all aspects of the abortion proce-
dure. An addition, the minimum required training and clinical
experience for each subtype of mid-level provider should be estab-
lished to enable better informed policy.
Although a large number of womenwere included in these studies,
relatively few providers have been included. In order to improve
the evidence base for the provision of abortion procedures bymid-
level providers, future studies should endeavour to include larger
numbers of providers.
Half of the studies included in the review were carried out in devel-
oping country settings (Jejeebhoy 2011; Jejeebhoy 2012;Warriner
2006; Warriner 2011); however, only one trial was carried out in
a rural developing country setting (Warriner 2011). The surgical
trial conducted in South Africa and Vietnam took place in Marie
Stopes International (MSI) clinics, which serve a population that
is slightly more educated and well-off than clients in the public
sector (Warriner 2006). Both of the Indian studies took place in
urban settings in non-governmental organisation (NGO) clinics
(Jejeebhoy 2011; Jejeebhoy 2012). As a result of this, women in
these studies may not be representative of women who attend
public clinics in developing country settings or rural women in
these countries. Only the Nepali medical abortion trial was car-
ried out in rural areas in a developing country setting (Warriner
2011). The training of mid-level providers to provide abortion
procedures aims to address shortages of trained physicians, par-
ticularly in rural areas (Berer 2009). As rural settings may pose
different challenges for mid-level providers carrying out abortion
procedures, such as a lack of access to primary care facilities for the
management of complications, we recommend that future studies
investigate the safety and effectiveness of the provision of surgical
abortion procedures by mid-level providers and doctors in rural
developing country settings.
In the Nepali medical abortion study, the participants’ demo-
graphic data were similar to the socio-demographic characteris-
tics of women typically seeking abortions in Nepal, suggesting
that the data are generalisable to Nepal. In addition, the trial
was carried out in low-resource settings in rural areas where mid-
level providers are more numerous and available than physicians
(Warriner 2011). These results suggest that the training of mid-
level providers for medical abortion could be scaled up in Nepal in
order to address shortages in the provision of safe abortion. How-
ever, caution should be applied in the interpretation of data that
come from trial conditions, therefore scaling up should be closely
monitored for safety and effectiveness.
Due to the shortage of physicians,mid-level providers are often the
only health professionals available in many settings. Given the po-
tential to expandwomen’s access to safe abortion inunderserved ar-
eas, mid-level provision has been widely advocated (Chong 2006;
IPAS 2002; Samora 2007). Training mid-level providers to pro-
vide first-trimester medical abortion and surgical abortion up to
12 weeks could facilitate widened access to safe termination, with
the potential to reduce the number of unsafe abortions and related
deaths and disabilities.
There is a significant difference in the risk of failure/incomplete
abortion(P value = 0.002) between mid-level providers and physi-
cians for surgical abortion, but the effect is small. The results sug-
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gest that for every 1000 procedures administered by a mid-level
provider, an additional four women (95% confidence interval (CI)
1 to 9) will experience abortion failure or incomplete abortion.
However, in the context of settings with a shortage of physicians
and a high incidence of unsafe abortion procedures, the potential
health gains associated with mid-level provision of abortion are
substantial. The current WHO unsafe abortion statistics estimate
that 22 million unsafe abortions take place every year, resulting in
five million complications (a 23% complication rate) and 47,000
deaths (Sedgh 2012). Even based on the assumption (from surgical
abortion randomised controlled trials (RCTs)) that the total com-
plication rate for procedures carried out by mid-level providers is
as high as 22/1000, if all unsafe abortions were carried out by mid-
level providers, there could be a 90% reduction in complications
and far fewer deaths (Chong 2006). A change in policy that al-
lows mid-level providers to carry out abortion procedures may not
achieve the theoretical reduction of 90% of complications, but it
will contribute to a reduction in the number of complications and
deaths caused by a lack of access to safe abortion. Compared to
the other potential complications that can occur, abortion failure
is not life-threatening in the majority of cases and its treatment
and management falls within the scope of the same providers.
There is no significant difference in the risk of immediate com-
plications between abortion procedures provided by mid-level
providers and those provided by physicians. In the context of a
developing country setting, where mid-level providers are likely to
be operating with limited support, these results are encouraging.
Adequate training and infrastructure are likely to be central to the
delivery of effective and safe abortion. The mid-level providers in
the studies included in this review were trained nurses, physician
assistants and midwives, who had experience in abortion proce-
dures or who were supervised by a qualified provider. National
reproductive health programmes need to evaluate how training
should be structured and implemented. Additionally, operational
research studies are needed to identify other types of mid-level
provider and to assess the feasibility and acceptability of rolling out
mid-level provision. Evaluations should also consider the structure
of the wider healthcare system and the availability of personnel, to
identify which mid-level providers are best placed to provide abor-
tion procedures and should also consider how the process from
pre- to post-abortion care is managed.
Quality of the evidence
According to the GRADE system (Higgins 2011), the majority of
the evidence is of lowor very lowquality. This is due to themajority
of data being derived fromnon-randomised, observational studies.
We considered the body of evidence derived fromRCTs of surgical
abortion to be of low quality due to inconsistencies between results
across studies. We considered the body of evidence on medical
abortion, which was derived from RCTs, to be of high quality.
However, these data come from a single study, therefore assessment
of inconsistency was not possible (Summary of findings for the
main comparison; Summary of findings 2).
A concern from the body of evidence derived from the cohort
studies is selection bias due to unconcealed allocation or differ-
ent eligibility criteria in study arms, which could lead to system-
atic differences in participant characteristics in the intervention
groups. This is problematic when these participant characteristics
may be associated with abortion outcomes, leading to differences
between the two groups that cannot be attributed solely to the
intervention. These differences were only reported in one of the
observational studies, where participants were from different US
states (Goldman 2004). The remaining four observational studies
reported similarities between the two groups of participants.
The studies included in this review did not blind either partici-
pants or outcome assessors. Although the reasons for this were not
explicitly stated we expect that this results in increased validity of
the body of evidence as this is consistent with non-trial conditions.
This review assesses the safety and efficacy of mid-level provision
of abortion services. Efficacy is reflected in the number of complete
abortions, therefore the primary outcome is defined as ongoing
pregnancy or incomplete abortion at follow-up. Further sub-anal-
ysis of ongoing pregnancy was not possible for surgical abortion
studies as only two studies separately reported ongoing pregnancy
and incomplete abortion in their results (Goldman 2004; Weitz
2013). In the medical abortion studies included in this review,
efficacy was reflected by the number of complete abortions. These
studies counted incomplete abortion and ongoing pregnancy as
failures. Therefore, we used the same definitions to alignwith these
studies when pooling the results to determine efficacy.
Potential biases in the review process
We minimised bias by conducting a thorough search in the
databases and by contacting the authors of studies for further in-
formation. Our search process was able to identify foreign lan-
guage studies that were indexed in English; however, we did not
search any foreign language databases.
The review was limited due to having only eight included studies,
only three of which were randomised controlled trials. As a result
of the different study designs, we carried out analysis of RCTs
independently of cohort studies.
Agreements and disagreements with other
studies or reviews
The systematic review that this Cochrane review updates reported
similar results (Ngo 2013), as did a similar review published in
2012 (Renner 2012). The present study has expanded on this
published review by including more recent findings from settings
where there is a shortage of providers and ahigh incidence of unsafe
abortions. These are the settings in which the implementation of
mid-level provision of abortion is likely to be a priority. Future
studies should also evaluate the feasibility of introducing mid-level
19Doctors or mid-level providers for abortion (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
provision in these settings.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Our findings suggest that mid-level providers can provide medical
abortion safely and effectively. Based on a small number of studies,
there may be some difference in the effectiveness of surgical abor-
tion procedures performed by mid-level providers compared with
physicians, however we cannot be sure. Observational data indi-
cate that there may be a higher risk of abortion failure for surgical
abortion procedures administered by mid-level providers, but the
number of studies is small and more robust data from controlled
trials are needed. There is no significant difference in the risk of
complications when surgical abortions are provided by mid-level
providers. If these findings are confirmed in further studies, in
settings with a shortage of trained providers coupled with a high
incidence of unsafe abortion, mid-level provision of terminations
could potentially reduce complications and death related to unsafe
abortion.
Implications for research
Further studies are required to establish the minimum level of
provider training and experience required for safe and effective
abortion procedures in both low and high-resource settings.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Freedman 1986
Methods 24-month cohort study
There was no differential allocation of patients between provider types. A patient could
request a particular provider if she desired. Less than 5% of clinic patients availed them-
selves of this option
Participants 2458 participants completed the study
All women who obtained abortions from a physician or a physician assistant at the
VermontWomen’s Health Center during the 2-year period from1 January 1981 through
31 December 1982
Gestation assessed by pelvic estimate
Contraindications included uterine sizing beyond 12 weeks gestation, current use of
anticoagulants, haematocrit less than 30%, prolonged bleeding time and active pelvic
inflammatory disease. Only procedures utilising local anaesthetics were performed at this
clinic
Interventions Physicians and physician assistants performed early uterine evacuation or suction curet-
tage at a Women’s Health Center in Vermont
Women arriving at the clinic were seen by the next available provider and were followed
up within 4 weeks of the procedure
MLPsworked independently to carry out abortions within the same site where physicians
were working
Outcomes Complication rates
Complications were placed into 1 of 7 categories:
-Uterine haemorrhage or “excessive bleeding”, as determinedby patient estimate (soaking
2 or more pads per hour for 4 to 6 hours)
- Uterine perforation
- Cervical laceration
- Incomplete abortion or retained products of conception
- Infection (fever 100.4 °F or higher on 2 readings and definite uterine tenderness)
- Post-abortion syndrome
- Vagal reaction (rapid drop in blood pressure followed by a short loss of consciousness)
Each complication was further classified as either immediate or delayed
Immediate complications were defined as those evident before the patient was discharged
from the clinic on the day of her procedure, while delayed complications were those
noted within the 4-week post-abortion period
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
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Freedman 1986 (Continued)
Random sequence generation (selection
bias)
Unclear risk No random sequence generation. Women
were seen by the next available provider.
However, only 5% of women opted for a
physician. The author states that randomi-
sation could have been natural
Allocation concealment (selection bias) High risk No allocation concealment
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk The participant was aware of the provider
type. We do not consider this to be a bias
because this is part of the intervention. If
MLPs are to perform abortion procedures
outside of study conditions, we would ex-
pect patients to be aware of the provider
type.We therefore do not consider the lack
of blinding to provider type to bias the re-
sults of the study
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No blinding of outcome assessment
Incomplete outcome data (attrition bias)
All outcomes
Low risk 96% follow-up - no difference stated be-
tween groups
Selective reporting (reporting bias) Unclear risk Not available
Other bias Low risk The study appears to be free of other
sources of bias
Goldman 2004
Methods 2-year cohort study of women undergoing surgically induced abortion in 2 clinics
Participants 1393 women completed the study
The study was carried out in the USA - in New Hampshire and Vermont clinic facilities
All women who underwent an outpatient surgical abortion performed by a physician at
the Feminist Health Center of Portsmouth, New Hampshire, or by a physician assistant
at the VermontWomen’s Health Center in Burlington, Vermont, between July 1996 and
October 1997 were eligible
There were no restrictions on gestational age but the majority were in the 1st trimester
Interventions Physicians with at least 5 years experience in abortion procedures performed standard
vacuum curettage procedures for pregnancies up to 12 weeks gestation at a clinic in New
Hampshire
Physician assistants with the same level of experience providedMVA or standard vacuum
curettage procedures for pregnancies up to 14 weeks gestation at a clinic in Vermont
Follow-up was within 14 days of the procedure
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Goldman 2004 (Continued)
Outcomes Complications:
Complications were defined according to National Abortion Federation guidelines as
follows:
- Incomplete abortion, in which tissue from the pregnancy remains in the uterus,
requiring a repeat abortion
- Failed abortion (continued pregnancy), in which the abortion does not end the preg-
nancy, requiring a repeat abortion
- Ectopic/extrauterine pregnancy, in which the signs and symptoms of pregnancy con-
tinue after abortion but no intrauterine pregnancy is detected
- Perforation, a condition in which a puncture or tear in the wall of the uterus or other
organ is present
- Cervical laceration, a condition in which a tear in the cervix is present, requiring either
sutures or vaginal packing
- Infection, which is detected by a temperature elevated to 100.4 °F or 38.0 °C, lower
abdominal pain or tenderness, and abnormal cervical discharge
- Haemorrhage, defined as blood loss estimated as 500 cc or greater (defined as bleeding
that was heavier than the heaviest day of a normal menstrual period or that soaked
through more than 1 sanitary pad per hour), which is caused by failure of the uterus to
contract and may require a blood transfusion
- Other complications, including shock, coma, amniotic fluid embolism, anaesthesia-
related
Complications were further classified as either immediate or delayed
Immediate complications were defined as those that occurred during the procedure or
before discharge from the clinic
Delayed complications were those that occurred up to 2 weeks after discharge difficulties,
and death
Notes All procedures performed by the physicians in New Hampshire were standard vacuum
curettage, whereas more than half of the physician assistant procedures (virtually all of
those performed at 8 weeks gestation or earlier) were manual vacuum curettage
The cannula sizes used by the 2 clinics differed. In Vermont, 95% of the manual vacuum
curettage procedures performed at 8 weeks gestation or earlier were performed with a 5
mm or 6 mm cannula. By contrast, in New Hampshire 96% of the standard vacuum
curettage procedures performed at 8 weeks gestation or earlier were performed with a 7
mm, 8 mm or 9 mm cannula
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk None. 2 clinics in 2 different US states:
providers in New Hampshire were physi-
cians, providers in Vermont were physi-
cian assistants. Characteristics of the par-
ticipants differed between the 2 settings
Allocation concealment (selection bias) High risk None
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Goldman 2004 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk The participant was aware of the provider
type. We do not consider this to be a bias
because this is part of the intervention. If
MLPs are to perform abortion procedures
outside of study conditions, we would ex-
pect patients to be aware of the provider
type.We therefore do not consider the lack
of blinding to provider type to bias the re-
sults of the study
Blinding of outcome assessment (detection
bias)
All outcomes
High risk None
Incomplete outcome data (attrition bias)
All outcomes
High risk 28.5% loss to follow-up - delayed compli-
cation data are likely to be affected
Selective reporting (reporting bias) Unclear risk No protocol available
Other bias High risk Physician assistants and physicians differed
in the methods of abortion used
Clinician training varied between clinics
Jejeebhoy 2011
Methods Cohort study
The study was located in 5 clinics in Bihar and Jharkhand, 2 poorly developed states of
India, in which access to health services is limited
Participants 865 women completed the study
Eligibility:
Positive uterine pregnancy of ≤ 10 weeks gestational age; no attempts in the previous
week to terminate the current pregnancy; resided within an hour of the study; willing to
return 7 days later (day 7) for a follow-up check-up and undergo 2 pelvic examinations
(by the study provider and supervisor); indicated no other contraindications for abortion
as per the Government of India guidelines
Interventions MVA delivered by nurses or physicians with no previous experience of providing any
type of abortion, who underwent MVA training as part of the study
All abortion procedures were conducted in the presence of a qualified supervisor
Women were followed up after 7 days
Outcomes Provider assessment of gestational age
Provider assessment of other criteria relating to eligibility
Provider assessment of complete abortion
Efficacy: complete abortion at day 7
Overall complication rate: including failure (failed abortion and adverse events - blood
transfusion, cervical injury, perforation, bowl injury, infection, hospitalisation)
26Doctors or mid-level providers for abortion (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Jejeebhoy 2011 (Continued)
Notes Supervisor assessment of outcomes
Women attending the clinics were unaware of the type of provider prior to attending
the clinic. The authors state that recruitment was naturally random
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No random sequence generation. Providers
were assigned to a facility for a certain pe-
riod of time. Clients who came for an abor-
tion were unaware of the type of clinician
whowould be providing services on the day
of the visit
Allocation concealment (selection bias) High risk None specified
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk The participant was aware of the provider
type. We do not consider this to be a bias
because this is part of the intervention. If
MLPs are to perform abortion procedures
outside of study conditions, we would ex-
pect patients to be aware of the provider
type.We therefore do not consider the lack
of blinding to provider type to bias the re-
sults of the study
Blinding of outcome assessment (detection
bias)
All outcomes
High risk None specified
Incomplete outcome data (attrition bias)
All outcomes
Low risk Missing outcome data are balanced in
numbers across intervention groups, with
similar reasons for missing data across
groups
Selective reporting (reporting bias) Unclear risk Protocol not available - the report alludes to
a protocol and summarises it in the meth-
ods but there is no published protocol
Other bias Low risk The study appears to be free of other
sources of bias
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Jejeebhoy 2012
Methods Cohort study
Carried out over 17 months in 2008-2010 in Bihar and Jharkhand, India. The study
was conducted in 5 NGO clinics
Participants 1164 women completed the study
Eligibility criteria:
The client needed to have a haemoglobin level of at least 9 g/dL, undergo 2 pelvic
examinations (by the study provider and verifier) and reside within an hour of the
study site; she would be ineligible if, during the past week, she had tried to terminate
the pregnancy using medication obtained from a chemist without a prescription. No
contraindications to medical abortion regimen
Interventions Medical abortion regimen of 200 mgmifepristone orally followed by 400 µg misoprostol
orally 2 days later for women up to 8 weeks gestation. The regimen was delivered by
ayurvedic physicians, nurses and allopathic physicians in abortion clinics in India. Only
providers who had never performed surgical or medical abortion, never conducted pelvic
examinations or assessed gestational age were recruited. All underwent identical medical
training, which lasted 10 days.Womenwere followed up after 15 and 21 days (if extended
follow-up was advised)
MLPs worked independently, though assessment was verified by a higher level clinician
Outcomes Complications: the percentage of women who experienced serious complications or
required a blood transfusion or hospitalisation
Incomplete abortion on day 15 or 21
The proportion of clients whose eligibility had been incorrectly assessed by their provider
(as compared with the verifier), including those who would have wrongly been denied
entry into the study and those who would have been wrongly recruited
The proportion of study participants whose abortion completeness status was incorrectly
assessed by the study provider
Notes Supervisors assessed providers’ accuracy of assessing eligibility and abortion completeness
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The study was not a randomised controlled
trial, as clients were not randomly assigned
to a particular type of provider. Providers
were assigned to a facility for a certain pe-
riod of time. Clients who came for an abor-
tion were unaware of the type of clinician
whowould be providing services on the day
of the visit or the type of physicians who
would succeed the current provider, as there
was no particular sequence
Allocation concealment (selection bias) High risk None
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Jejeebhoy 2012 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk The participant was aware of the provider
type. We do not consider this to be a bias
because this is part of the intervention. If
MLPs are to perform abortion procedures
outside of study conditions, we would ex-
pect patients to be aware of the provider
type.We therefore do not consider the lack
of blinding to provider type to bias the re-
sults of the study
Blinding of outcome assessment (detection
bias)
All outcomes
High risk None
Incomplete outcome data (attrition bias)
All outcomes
Low risk The confidence intervals for the differences
in loss to follow-up fell within the prede-
termined margin of statistical equivalence
for each provider type, both for day 3 and
for day 15 or 21
Selective reporting (reporting bias) Unclear risk No protocol available
Other bias Unclear risk A break in recruitment due to unavailable
study providers produced a long study pe-
riod
Kopp Kallner 2015
Methods Randomised controlled trail
Carried out in 2011-2012 in Sweden in an outpatient family planning clinic
Women who made an appointment by calling the clinic by telephone were informed
about the study and invited to participate
Participants Women were eligible to participate if they: had a gestation of 63 days or less according to
their last menstrual period; were 18 years or older; had no contraindication for medical
abortion; were in good general health; were not taking any continuing medication for
chronic disease
Interventions 2 nursemidwives experienced inmedical abortion and contraceptive counselling received
theoretical and practical training in vaginal ultrasound examination of early pregnancy
These nurse midwives were the sole providers in the nurse midwife arm
There were a total of 34 doctors with varying levels of training and experience in the
standard care arm
Women randomised to the nurse-midwife arm were counselled, examined, informed
and treated by a single nurse midwife. Nurse-midwives in this arm did not perform any
other tasks during the study period
Women randomised to the standard care armwere examined and counselled by the doctor
and then received additional information about the practical details andmedication from
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Kopp Kallner 2015 (Continued)
a nurse midwife, according to clinical routine
All women received 200 mg of mifepristone in the clinic
Women then had the choice of receiving 800 µg ofmisoprostol vaginally at home or in the
clinic 24 to 48 hours after mifepristone administration. If no bleeding occurred within 3
hours, women were instructed to take an additional dose of 400 µg of misoprostol orally
Women were followed up after 3 weeks and given a urinary hCG test. If the results were
positive a serum hCG test was performed and they were referred for evaluation with
vaginal ultrasound
Complications were followed up for 6 weeks
MLPs and doctors worked at the same site
Outcomes The primary outcome was efficacy, defined as the need for surgical intervention
Secondary outcomes:
Safety, defined as no complications up to 6 weeks after the procedure
Hospitalisation or blood transfusion
Acceptability, defined as women preferring their allocated provider
Outcomes were assessed by questionnaires at follow-up visit
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated sequence
Allocation concealment (selection bias) Low risk Sealed, opaque envelopes
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk The participant was aware of the provider
type. We do not consider this to be a bias
because this is part of the intervention. If
MLPs are to perform abortion procedures
outside of study conditions, we would ex-
pect patients to be aware of the provider
type.We therefore do not consider the lack
of blinding to provider type to bias the re-
sults of the study
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk Low loss to follow-up, similar in each group
Selective reporting (reporting bias) Low risk Protocol made available prior to study
Other bias Unclear risk No other bias detected
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Warriner 2006
Methods Randomised controlled trial
The study was carried out in South Africa from September 2003 to June 2004 and in
Vietnam from May to December 2003
Randomisation was done separately for each clinic using a block design with about 600
women in each centre and a ratio of 1:1 for doctors and MLPs. The random allocation
sequence was generated using SAS by a data management team at WHO in Geneva,
Switzerland
Sealed, opaque envelopes containing the random allocation of the type of provider
were sequentially numbered and were opened when written informed consent had been
provided
Women were not blinded to their provider type
Participants 1153 women completed the study in South Africa. All women presenting for an abortion
at 2 MSI clinics in the Western Cape Province and 2 MSI clinics in KwaZulu Natal
province were invited to take part if they met the eligibility criteria
1636 women completed the study in Vietnam. All women presenting for an abortion at
4 MSI clinics in Ha Tinh, Ho Chi Minh City, Nghe An and Thai Binh were invited to
take part in the study if they met the eligibility criteria
Clinics in both countries were located in urban and peri-urban areas and served mainly
lower middle-class women
Eligibility criteria:
All women who presented for a first-trimester abortion during the study period were
informed of the study and invited to participate
Women met medical eligibility criteria if they were: at least 18 years old; the gestational
age of the pregnancywas less than 12 completedweeks as estimated by pelvic examination
and date of last menstrual period
Data from ultrasound examinations, done routinely at MSI clinics, were also obtained
to ensure that eligibility criteria were met
Additional eligibility criteria were: residence within a specified geographical area; will-
ingness to be randomly assigned to a provider; willingness to return to the clinic for
follow-up or to be interviewed at home (or another mutually agreed upon location) or
by telephone, 10 to 14 days after the abortion. Additionally, women were required to
provide written informed consent
Gestation < 12 weeks assessed by ultrasound
Interventions MVA delivered by MLPs with government-accredited training in abortion, and those
administered by physicians. All participants were offered lidocaine and additional oral
analgesia; in one of the study locations (South Africa), misoprostol 400 mg was admin-
istered 2 to 3 hours before the procedure (reference). Women were followed up 10 to 14
days after the procedure
MLPs and doctors worked at the same site
Outcomes Compared outcomes of MVA procedures for pregnancies up to 12 weeks gestation
delivered byMLPswith government-accredited training in abortion and those procedures
administered by physicians
Abortion complications
(i) Collected at the time of abortion/before leaving clinic and at follow-up 10 to 14 days
later
(ii) Reported: at follow-up interviews
Immediate complications: excess bleeding (> 500 cc) after abortion, cervical injury,
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confirmed/suspected perforation, adverse drug reaction
Delayed complication: retained POC needing re-evacuation, haematometra, post-abor-
tion pelvic infection, excessive post-abortion bleeding (> 500 cc), abortion-related death
Percentage of complication types per group
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Adequate randomisation: “computer gen-
erated randomisation list”
Allocation concealment (selection bias) Low risk Sealed, opaque envelopes; opened once
written informed consent obtained
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk The participant was aware of the provider
type. We do not consider this to be a bias
because this is part of the intervention. If
MLPs are to perform abortion procedures
outside of study conditions, we would ex-
pect patients to be aware of the provider
type.We therefore do not consider the lack
of blinding to provider type to bias the re-
sults of the studys
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Interviewer was a 3rd party, however they
were not blinded to the provider type
Incomplete outcome data (attrition bias)
All outcomes
Low risk Low
Selective reporting (reporting bias) Unclear risk Pre-specified outcomes were reported; pro-
tocol not published
Other bias Low risk The study appears to be free of other
sources of bias
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Warriner 2011
Methods Randomised controlled trial.
Multicentre randomised controlled equivalence trial, which took place over 11 months
Sequence generation:
Computer-generated randomisation scheme stratified by study centre with a block size
of 6. The random allocation sequence was generated by the use of SAS software (SAS
Institute, Cary, NC, USA)
Allocation sequence concealment:
Sealed, opaque envelopes containing the randomallocationwere consecutively numbered
and were opened and assigned sequentially to women by a research assistant once written
informed consent had been obtained
Blinding: blinded to research assistant
Participants 1032 women completed the study in 5 rural district hospitals in Nepal. Data were
collected between 15 April 2009 and 17 March 2010
Eligibility:
Providers: only providers trained in manual vacuum aspiration were eligible for medical
abortion training
Patients: less than 9 weeks (≤ 63 days) of gestation according to date of last menstrual
period and as estimated by bimanual pelvic examination, older than 16 years, resided no
more than 90 minutes journey from the study clinic and willing to be randomly assigned
to a provider, to return to the clinic 10 to 14 days after the start of treatment and to
provide written informed consent
Interventions Medical abortion regimen of 200 mg mifepristone orally followed by 800 mg of miso-
prostol vaginally 1 to 2 days later, delivered by MLPs (staff nurses and auxiliary mid-
wives) trained in MVA, or doctors (obstetricians, gynaecologists, general practitioners
and other doctors) across 5 district hospitals in Nepal. Women were followed up 10 to
14 days after the procedure
MLPs and doctors worked from the same site, though waiting areas and examination
rooms were separated to reduce interaction between providers
Outcomes The primary endpoint was complete abortion without manual vacuum aspiration within
30 days of treatment
Failed abortion (continuing pregnancy) was recorded when clinical examination indi-
cated continuing symptoms of pregnancy and manual vacuum aspiration was needed to
terminate the pregnancy
Incomplete abortion was defined as products of conception remaining in the uterus with
continued bleeding, bulky uterus and open cervix at examination, possibly necessitating
surgical evacuation at the discretion of the provider or at the woman’s request
Women were also asked whether they had visited any non-study hospital, clinic or
provider during the study
The secondary endpoint measured case management decisions by recording case man-
agement discussion and referrals between providers to assess the extent to which each
group provided medical abortion services independently
Serious adverse events (haemorrhage necessitating blood transfusion, conditions neces-
sitating hospitalisation) were recorded
Notes A limitation of the study is that although separate waiting and examination rooms for
the 2 groups were set up for the duration of the study, both types of providers worked in
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the same hospital and in the same environment. Although this controlled environment
optimised comparison, it might have led to a convergence of outcomes that would not
have happened if the women had been assigned to providers at different clinics
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generation using SAS
Allocation concealment (selection bias) Low risk Sequential, sealed, opaque envelopes
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk The participant was aware of the provider
type. We do not consider this to be a bias
because this is part of the intervention. If
MLPs are to perform abortion procedures
outside of study conditions, we would ex-
pect patients to be aware of the provider
type.We therefore do not consider the lack
of blinding to provider type to bias the re-
sults of the study
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No blinding of outcome assessment, but
the review authors judge that the outcome
measurement is not likely to be influenced
by lack of blinding
Outcomewas assessed by the same provider
type that carried out the abortion - poten-
tially the same provider
Observer bias
Incomplete outcome data (attrition bias)
All outcomes
Low risk Loss to follow-up of women receiving treat-
ment was 24 of 542 (4%) in the mid-level
health care providers group and 19 of 535
(4%) in the doctors group. Women lost to
follow-up were, on average, less educated
than those followed up. Two women in the
doctors group were excluded from the anal-
ysis because at follow-up they were shown
not to have been pregnant: one was a long-
time user of a 3-monthly injectable contra-
ceptive, and the other one had had a man-
ual vacuum aspiration 37 days before
Selective reporting (reporting bias) Unclear risk Protocol not published
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Other bias Low risk The study appears to be free of other
sources of bias
Weitz 2013
Methods Cohort study carried out over 4 years in California, USA
Participants 11,487 women completed the study. The study was carried out in a private facility
hospital and private clinic in California, USA between August 2007 and August 2011
Eligibility:
Aged 16 years or older (18 years at Planned Parenthood affiliates), seeking a first trimester
aspiration abortion (facilities self defined this as < 12 or < 14 weeks gestation by ultra-
sound), could speak English or Spanish
Patients were excluded if they requested general anaesthesia or did not meet the health-
related criteria (unexplained historical, physical or laboratory findings or known or sus-
pected cervical or uterine abnormalities)
Interventions In this prospective, observational cohort study, NPs, CNMs and PAs from 5 partner
organisations (4 Planned Parenthood affiliates and KPNC)
The study compared complication rates within 4 weeks of aspiration abortion for nurse
practitioners, certified nurse midwives and physician assistants to those of physicians.
Providers were trained to competency in the provision of aspiration abortion (aminimum
of 40 procedures over 6 clinical days, with competence assessed by an authorised physi-
cian trainer) and had a California professional licence and basic life support. Providers
performed aspiration abortion on participants with < 14 weeks gestation. Follow-up was
within 4 weeks of procedure
MLPs and doctors worked from the same site
Outcomes The primary outcome was the difference in the incidence of complications within 4
weeks of the aspiration abortion between NPs, CNMs and PAs and physicians
Complications were categorised as immediate (occurring before leaving the facility) and
delayed (occurring < 4 weeks after the procedure)
Complications were classified as major if the patient required hospital admission, surgery
or a blood transfusion and minor if they were treated at home or in an outpatient setting
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No random sequence generation, however
a lack of randomisation was adjusted for in
analysis using propensity score matching
Allocation concealment (selection bias) High risk None
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Blinding of participants and personnel
(performance bias)
All outcomes
Low risk The participant was aware of the provider
type. We do not consider this to be a bias
because this is part of the intervention. If
MLPs are to perform abortion procedures
outside of study conditions, we would ex-
pect patients to be aware of the provider
type.We therefore do not consider the lack
of blinding to provider type to bias the re-
sults of the study
Blinding of outcome assessment (detection
bias)
All outcomes
High risk A further limitation of the study is that the
health care provider who initially identified
a complication was not blinded to the type
of provider who performed the abortion
Incomplete outcome data (attrition bias)
All outcomes
Low risk 30% loss to follow-up
Complications between groups compared
“Although postprocedure complications
may have been missed among patients for
whom we did not have follow-up data,
given the nondifferential follow-up rates
between provider groups, we would expect
unidentified complications to be equally
distributed between groups, leaving the risk
difference unaffected.”
Selective reporting (reporting bias) Low risk Protocol published
Other bias Low risk The study appears to be free of other
sources of bias
CNM: certified nurse midwife
hCG: human chorionic gonadotropin
KPNC: Kaiser Permanente of Northern California
MLP: mid-level provider
MSI: Marie Stopes International
MVA: manual vacuum aspiration
NGO: non-governmental organisation
NP: nurse practitioner
PA: physician assistant
POC: products of conception
WHO: World Health Organization
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Donovan 1992 Narrative piece on physician assistants performing abortions and training residents
Igberase 2008 Descriptive study of complications of abortion; no comparison group
IPPF 2001 No comparison group
Neustatter 1980 No comparison group
Shaikh 2010 Analysis of hospital-based data quantifying unsafe abortion
Shamash 2002 Commentary piece
Characteristics of studies awaiting assessment [ordered by study ID]
Safe Motherhood 1992
Methods Title could not be retrieved
Participants Title could not be retrieved
Interventions Title could not be retrieved
Outcomes Title could not be retrieved
Notes Title could not be retrieved
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D A T A A N D A N A L Y S E S
Comparison 1. Mid-level providers versus doctors
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Failure/incomplete surgical
abortion (RCTs)
1 2789 Risk Ratio (M-H, Random, 95% CI) 2.97 [0.21, 41.82]
2 Failure/incomplete surgical
abortion (observational studies)
3 13715 Risk Ratio (M-H, Fixed, 95% CI) 2.25 [1.38, 3.68]
3 Complications: surgical abortion
(RCTs)
1 2789 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.17, 5.70]
4 Complications: surgical abortion
(observational studies)
3 13715 Risk Ratio (M-H, Random, 95% CI) 1.38 [0.70, 2.72]
5 Failure/incomplete abortion
and complications: surgical
abortion (RCTs)
1 2789 Risk Ratio (M-H, Random, 95% CI) 3.07 [0.16, 59.08]
6 Total failures/incomplete
abortion and complications:
surgical abortion
(observational)
4 16173 Risk Ratio (M-H, Random, 95% CI) 1.36 [0.86, 2.14]
7 Failure/incomplete medical
abortion (RCTs)
2 1892 Risk Ratio (M-H, Fixed, 95% CI) 0.81 [0.48, 1.36]
8 Failure/incomplete medical
abortion (Jejeebhoy 2012)
(observational)
1 1164 Risk Ratio (M-H, Fixed, 95% CI) 1.09 [0.63, 1.88]
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Analysis 1.1. Comparison 1 Mid-level providers versus doctors, Outcome 1 Failure/incomplete surgical
abortion (RCTs).
Review: Doctors or mid-level providers for abortion
Comparison: 1 Mid-level providers versus doctors
Outcome: 1 Failure/incomplete surgical abortion (RCTs)
Study or subgroup MLPs Doctors Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Warriner 2006 7/576 0/577 37.8 % 15.03 [ 0.86, 262.48 ]
Warriner 2006 9/824 8/812 62.2 % 1.11 [ 0.43, 2.86 ]
Total (95% CI) 1400 1389 100.0 % 2.97 [ 0.21, 41.82 ]
Total events: 16 (MLPs), 8 (Doctors)
Heterogeneity: Tau2 = 2.69; Chi2 = 3.28, df = 1 (P = 0.07); I2 =70%
Test for overall effect: Z = 0.81 (P = 0.42)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours MLPs Favours doctors
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Analysis 1.2. Comparison 1 Mid-level providers versus doctors, Outcome 2 Failure/incomplete surgical
abortion (observational studies).
Review: Doctors or mid-level providers for abortion
Comparison: 1 Mid-level providers versus doctors
Outcome: 2 Failure/incomplete surgical abortion (observational studies)
Study or subgroup MLPs Doctors Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Goldman 2004 8/546 3/817 10.8 % 3.99 [ 1.06, 14.97 ]
Jejeebhoy 2011 5/433 4/432 18.0 % 1.25 [ 0.34, 4.61 ]
Weitz 2013 35/5675 16/5812 71.2 % 2.24 [ 1.24, 4.04 ]
Total (95% CI) 6654 7061 100.0 % 2.25 [ 1.38, 3.68 ]
Total events: 48 (MLPs), 23 (Doctors)
Heterogeneity: Chi2 = 1.50, df = 2 (P = 0.47); I2 =0.0%
Test for overall effect: Z = 3.23 (P = 0.0013)
Test for subgroup differences: Not applicable
0.005 0.1 1 10 200
Favours MLPs Favours doctors
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Analysis 1.3. Comparison 1 Mid-level providers versus doctors, Outcome 3 Complications: surgical abortion
(RCTs).
Review: Doctors or mid-level providers for abortion
Comparison: 1 Mid-level providers versus doctors
Outcome: 3 Complications: surgical abortion (RCTs)
Study or subgroup MLPs Doctors Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Warriner 2006 1/824 2/812 80.1 % 0.49 [ 0.04, 5.42 ]
Warriner 2006 1/576 0/577 19.9 % 3.01 [ 0.12, 73.62 ]
Total (95% CI) 1400 1389 100.0 % 0.99 [ 0.17, 5.70 ]
Total events: 2 (MLPs), 2 (Doctors)
Heterogeneity: Chi2 = 0.79, df = 1 (P = 0.37); I2 =0.0%
Test for overall effect: Z = 0.01 (P = 0.99)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours MLPs Favours doctors
Analysis 1.4. Comparison 1 Mid-level providers versus doctors, Outcome 4 Complications: surgical abortion
(observational studies).
Review: Doctors or mid-level providers for abortion
Comparison: 1 Mid-level providers versus doctors
Outcome: 4 Complications: surgical abortion (observational studies)
Study or subgroup MLPs Doctors Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Goldman 2004 9/546 17/817 37.1 % 0.79 [ 0.36, 1.76 ]
Jejeebhoy 2011 1/433 0/432 4.2 % 2.99 [ 0.12, 73.27 ]
Weitz 2013 58/5675 32/5812 58.7 % 1.86 [ 1.21, 2.85 ]
Total (95% CI) 6654 7061 100.0 % 1.38 [ 0.70, 2.72 ]
Total events: 68 (MLPs), 49 (Doctors)
Heterogeneity: Tau2 = 0.16; Chi2 = 3.54, df = 2 (P = 0.17); I2 =43%
Test for overall effect: Z = 0.94 (P = 0.35)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours MLPs Favours doctors
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Analysis 1.5. Comparison 1 Mid-level providers versus doctors, Outcome 5 Failure/incomplete abortion and
complications: surgical abortion (RCTs).
Review: Doctors or mid-level providers for abortion
Comparison: 1 Mid-level providers versus doctors
Outcome: 5 Failure/incomplete abortion and complications: surgical abortion (RCTs)
Study or subgroup MLPs Doctors Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Warriner 2006 10/824 10/812 60.1 % 0.99 [ 0.41, 2.35 ]
Warriner 2006 8/576 0/577 39.9 % 17.03 [ 0.99, 294.35 ]
Total (95% CI) 1400 1389 100.0 % 3.07 [ 0.16, 59.08 ]
Total events: 18 (MLPs), 10 (Doctors)
Heterogeneity: Tau2 = 3.59; Chi2 = 4.10, df = 1 (P = 0.04); I2 =76%
Test for overall effect: Z = 0.74 (P = 0.46)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours MLPs Favours doctors
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Analysis 1.6. Comparison 1 Mid-level providers versus doctors, Outcome 6 Total failures/incomplete
abortion and complications: surgical abortion (observational).
Review: Doctors or mid-level providers for abortion
Comparison: 1 Mid-level providers versus doctors
Outcome: 6 Total failures/incomplete abortion and complications: surgical abortion (observational)
Study or subgroup MLPs Doctors Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Freedman 1986 35/1285 36/1173 30.7 % 0.89 [ 0.56, 1.40 ]
Goldman 2004 17/546 20/817 23.8 % 1.27 [ 0.67, 2.41 ]
Jejeebhoy 2011 6/433 4/432 10.1 % 1.50 [ 0.43, 5.27 ]
Weitz 2013 93/5675 48/5812 35.4 % 1.98 [ 1.40, 2.81 ]
Total (95% CI) 7939 8234 100.0 % 1.36 [ 0.86, 2.14 ]
Total events: 151 (MLPs), 108 (Doctors)
Heterogeneity: Tau2 = 0.12; Chi2 = 7.73, df = 3 (P = 0.05); I2 =61%
Test for overall effect: Z = 1.31 (P = 0.19)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Favours MLPs Favours doctors
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Analysis 1.7. Comparison 1 Mid-level providers versus doctors, Outcome 7 Failure/incomplete medical
abortion (RCTs).
Review: Doctors or mid-level providers for abortion
Comparison: 1 Mid-level providers versus doctors
Outcome: 7 Failure/incomplete medical abortion (RCTs)
Study or subgroup MLPs Doctors Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Kopp Kallner 2015 12/473 13/443 43.3 % 0.86 [ 0.40, 1.87 ]
Warriner 2011 14/504 17/472 56.7 % 0.77 [ 0.38, 1.55 ]
Total (95% CI) 977 915 100.0 % 0.81 [ 0.48, 1.36 ]
Total events: 26 (MLPs), 30 (Doctors)
Heterogeneity: Chi2 = 0.05, df = 1 (P = 0.83); I2 =0.0%
Test for overall effect: Z = 0.79 (P = 0.43)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours MLPs Favours doctors
Analysis 1.8. Comparison 1 Mid-level providers versus doctors, Outcome 8 Failure/incomplete medical
abortion (Jejeebhoy 2012) (observational).
Review: Doctors or mid-level providers for abortion
Comparison: 1 Mid-level providers versus doctors
Outcome: 8 Failure/incomplete medical abortion (Jejeebhoy 2012) (observational)
Study or subgroup MLPs Doctors Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Jejeebhoy 2012 39/775 18/389 100.0 % 1.09 [ 0.63, 1.88 ]
Total (95% CI) 775 389 100.0 % 1.09 [ 0.63, 1.88 ]
Total events: 39 (MLPs), 18 (Doctors)
Heterogeneity: not applicable
Test for overall effect: Z = 0.30 (P = 0.76)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours MLPs Favours doctors
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A P P E N D I C E S
Appendix 1. MEDLINE via Pubmed search strategy
Search 1
All fields: (Nurses“[Mesh] OR ”Physician Assistants“[Mesh] OR ”mid-level provider“[text word] OR ”mid-level providers“[text word]
OR nurse*[text word] OR midwife*[text word] OR midwives[text word] OR ”nurse practitioner“[text word] OR ”nurse practition-
ers“[text word] OR ”physician assistant“[text word] OR ”physician assistants“[text word] OR ”non-physician“[text word] OR ”non-
physicians“[text word] OR ”substitute health worker“[text word] OR ”substitute health workers“[text word] OR auxiliar*[text word])
AND (”Abortion, Incomplete“[Mesh] OR ”Abortion, Induced“[Mesh:noexp] OR ”Abortion, Legal“[Mesh] OR ”Abortion, Thera-
peutic“[Mesh:noexp] OR abortion*[text word])
Search results were restricted to studies published after 1980 through to August 15 2014.
We placed no limits on language.
Replicated PubMed Strategy in Cochrane CENTRAL: 24 unique citations
Appendix 2. POPLINE search strategy
Search 1: 193
All fields: (”mid-level provider“ OR ”mid-level providers“ OR nurse* OR midwife* OR midwives OR ”nurse practitioner“ OR ”nurse
practitioners“ OR ”physician assistant“ OR ”physician assistants“ OR ”non-physician“ OR ”non-physicians“ OR ”substitute health
worker“ OR ”substitute health workers“OR auxiliar*) AND abortion*
Search 2: 141 citations
All fields: ”mid-level provider“ OR ”mid-level providers“ OR nurse* OR midwife* OR midwives OR ”nurse practitioner“ OR ”nurse
practitioners“ OR ”physician assistant“ OR ”physician assistants“ OR ”non-physician“ OR ”non-physicians“ OR ”substitute health
worker“ OR ”substitute health workers“OR auxiliar*
AND
Keywords: abortion
Search 3: 79 citations
All Fields: abortion*
AND
Keywords (MIDWIVES ANDMIDWIFERY OR Traditional Birth Attendants OR PARAMEDICAL PERSONNELOR Nurses and
Nursing OR Nurse-Midwives)
Unique citations from Popline from 1980 through to August 15 2014
We deleted duplicated using EndNote and then removed citations older than 1980.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Types of Participants, was amended to state that women seeking abortions should be ”gestational age less than 14 weeks for surgical
abortion and less than nine weeks for medical abortion“.
Types of Intervention, was amended to provide the following specific description of mid-level providers; ”Mid-level providers included
nurses, nurse practitioners, ayurvedic practitioners, physician assistants, midwives, auxiliary nurse midwives and certified nurse midwives.
Mid-level providers worked independently when carrying out the abortion procedure“.
Types of Outcome Measures was amended to include a new ‘secondary outcome’:“Total complications (incomplete or failed abortion and
complications)”.
Subgroup analysis’: Not all subgroup analyses were performed. Subgroup analysis of MLP type could not be performed due to
heterogeneity between MLP types. Subgroup analysis of healthcare setting was not carried out due to heterogenity between healthcare
settings.
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Medical Subject Headings (MeSH)
Abortifacient Agents; Abortion, Legal [∗adverse effects; education; standards]; Abortion, Therapeutic [∗adverse effects; education;
standards]; AlliedHealth Personnel [education; ∗standards]; Clinical Competence [∗standards]; Cohort Studies; Midwifery [education;
standards]; Mifepristone; Misoprostol; Nurses [∗standards]; Nurses’ Aides [education; standards]; Observational Studies as Topic;
Physician Assistants [education; standards]; Physicians [∗standards]; Pregnancy Trimester, First; Randomized Controlled Trials as Topic;
Vacuum Curettage [adverse effects]
MeSH check words
Female; Humans; Pregnancy
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